Recruiting NCT04641936
— Observational Taiwan
Metastatic Urothelial Carcinoma
Recruiting NCT04838899
No phase Interventional Canada
Oligoprogressive · Castration-Resistant Prostate Cancer
Recruiting NCT06354231
Phase II Interventional China
Renal Insufficiency · Upper Urinary Tract Urothelial Carcinoma · Solitary Kidney
Recruiting NCT06336187
— Observational Italy
Renal Cell Carcinoma
Not yet recruiting NCT06355518
No phase Interventional Italy
Bladder Cancer
Recruiting NCT06350825
Phase III Interventional China
Metastatic Prostate Cancer · Therapy, Directly Observed
Recruiting NCT06341478
No phase Interventional Italy
Bladder Cancer
Recruiting NCT06343077
Phase II Interventional United States
Prostate Cancer Patients on Active Surveillance
Recruiting NCT06335693
No phase Interventional China
Prostate Cancer
Recruiting NCT03973671
— Observational Belgium
Urinary Bladder Neoplasms
Not yet recruiting NCT06325423
— Observational —
Muscle-Invasive Bladder Carcinoma
Recruiting NCT06330909
No phase Interventional Germany
Prostate Cancer
Not yet recruiting NCT06327932
Phase III Interventional —
Non-Muscle-Invasive Bladder Cancer
Recruiting NCT06320223
— Observational Germany
Prostate Cancer · PET/CT · Survivorship
Recruiting NCT06321679
— Observational Italy
Castration-resistant Prostate Cancer
Recruiting NCT06318559
No phase Interventional Italy
Cancer of Prostate
Recruiting NCT05116475
Phase III Interventional France
Prostate Cancer
Recruiting NCT06200987
No phase Interventional Denmark
Erectile Dysfunction Following Radical Prostatectomy · Incontinence
Recruiting NCT06305832
Phase II Interventional China
Prostate Cancer · Biochemical Recurrence
Recruiting NCT06294951
— Observational China
Bladder Pain Syndrome
Recruiting NCT06292897
— Observational Italy
Prostate Cancer · Prostate Adenocarcinoma · Prostate Neoplasm
Recruiting NCT06289270
— Observational Egypt
Microbiota in Patients With Urinary Bladder Carcinoma in Urine and Cancer Tissues
Recruiting NCT06287541
No phase Interventional China
Non Muscle Invasive Bladder Cancer
Recruiting NCT04612907
No phase Interventional Sweden
Prostate Cancer · Radiotherapy Side Effect · Metastatic Cancer
Not yet recruiting NCT06188533
— Observational —
Urinary Activin A in AKI
Not yet recruiting NCT06137300
No phase Interventional China
Acute Ischemic Stroke
Enrolling by invitation NCT02526797
— Observational Denmark
Prostatic Neoplasms
Recruiting NCT04642027
Phase III Interventional Netherlands
Prostate Cancer · Cancer Recurrence
Not yet recruiting NCT06279403
Phase II Interventional —
Clear-cell Metastatic Renal Cell Carcinoma · Immune Checkpoint Inhibitors · Cytoreductive Nephrectomy
Recruiting NCT06270043
— Observational United States
Prostate Cancer
Recruiting NCT06278506
No phase Interventional Sweden
Kidney Cancer
Recruiting NCT06269536
No phase Interventional Slovakia
Bladder Cancer
Not yet recruiting NCT06271551
Phase II Interventional —
Prostate Cancer
Recruiting NCT06223295
No phase Interventional Netherlands
Prostate Cancer · Prostate Neoplasm
Recruiting NCT06041555
— Observational France
Prostate Cancer · Glioblastoma · Head and Neck Cancer
Not yet recruiting NCT05707468
No phase Interventional China
Oligometastatic Prostate Carcinoma
Recruiting NCT06259123
Phase II Interventional Austria
Prostate Cancer
Not yet recruiting NCT06255964
Phase I / Phase II Interventional —
Bladder Cancer
Recruiting NCT06220188
Phase II Interventional Austria
Prostate Cancer Recurrent
Recruiting NCT06249750
Phase II Interventional China
Metastatic Castration-resistant Prostate Cancer (CRPC)
Recruiting NCT06241755
Phase III Interventional China
Non-Muscle Invasive Bladder Cancer
Not yet recruiting NCT04147793
— Observational United Kingdom
Dysfunctional Voiding · Stress Incontinence, Urinary
Recruiting NCT06239909
— Observational Czechia
Urinary Incontinence
Recruiting NCT06236789
— Observational South Korea
Prostatic Neoplasm
Recruiting NCT05731622
— Observational Netherlands
Upper Urinary Tract Carcinoma
Recruiting NCT03414827
— Observational Denmark
Kidney Cancer
Recruiting NCT05013944
— Observational United States
Infectious Disease · Neoplasms · Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)
Recruiting NCT03857373
— Observational Denmark
Kidney Cancer
Not yet recruiting NCT06227065
Phase II Interventional Switzerland
Bladder Cancer · Non-muscle Invasive Bladder Cancer · Low-risk
Not yet recruiting NCT04176081
Phase II Interventional Canada
Prostate Cancer
Recruiting NCT06218927
— Observational Czechia
Multiple Sclerosis · Lower Urinary Tract Symptoms
Recruiting NCT06219746
No phase Interventional Finland
Prostate Cancer
Recruiting NCT06211790
Phase II Interventional China
Kidney Cancer · Renal Cell Carcinoma · Renal Clear Cell Carcinoma
Recruiting NCT03044223
— Observational Germany
Pseudomonas Infections · Pseudomonas Septicemia · Pseudomonas; Pneumonia
Recruiting NCT06204406
— Observational China
Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy
Not yet recruiting NCT06198387
No phase Interventional China
Oligo-metastatic Prostate Carcinoma
Recruiting NCT06194669
— Observational Italy
Carcinoma, Renal Cell · Von Hippel-Lindau Disease
Recruiting NCT04831983
— Observational Italy
Prostate Cancer
Not yet recruiting NCT05411354
— Observational United States
Prostate Cancer
Recruiting NCT04084938
No phase Interventional Norway
Benign Prostatic Hyperplasia · Post-Op Complication · Embolization Therapeutic
Recruiting NCT06177015
Phase III Interventional China
Metastatic Prostate Cancer · Intermitent Anti-androgen Therapy
Recruiting NCT05302284
Phase III Interventional China
Urothelial Carcinoma · HER2-expressing
Recruiting NCT06170177
— Observational Italy
Muscle-Invasive Bladder Carcinoma · Muscle Invasive Bladder Urothelial Carcinoma · Bladder Cancer TNM Staging
Recruiting NCT06169436
— Observational Italy
Upper Urinary Tract Urothelial Carcinoma
Recruiting NCT04242017
Phase II / Phase III Interventional Belgium
Prostate Cancer
Recruiting NCT06167629
— Observational Italy
Prostate Cancer
Recruiting NCT06167356
— Observational Italy
Non Muscle Invasive Bladder Cancer · Non-Muscle Invasive Bladder Neoplasms · Non-Muscle Invasive Bladder Urothelial Carcinoma
Not yet recruiting NCT06132880
No phase Interventional —
Acute Ischemic Stroke · Functional Outcomes
Not yet recruiting NCT06146777
Phase III Interventional —
Papillary Renal Cell Carcinoma
Recruiting NCT05767307
— Observational Denmark
Prostate Cancer
Enrolling by invitation NCT03459820
Phase II / Phase III Interventional Canada
Prostate Cancer
Recruiting NCT06147349
— Observational Italy
Renal Cancer
Not yet recruiting NCT06145958
— Observational —
Prostate Cancer
Not yet recruiting NCT06142500
No phase Interventional —
Testicular Cancer
Recruiting NCT05781217
Phase III Interventional Spain
Prostate Cancer · Salvage Radiotherapy · Biochemical Recurrence
Not yet recruiting NCT06136377
No phase Interventional —
Patients With Metastatic Castration-resistant Prostate Cancer
Not yet recruiting NCT06129851
Phase II Interventional United States
Stage IIC Prostate Cancer AJCC v8 · Stage III Prostate Cancer AJCC v8 · Stage IV Prostate Cancer AJCC v8
Recruiting NCT06120387
— Observational China
Locally Advanced · Urothelial Carcinoma Ureter
Recruiting NCT06116396
— Observational Italy
Urothelial Carcinoma
Recruiting NCT06116851
— Observational Finland
Prostate Cancer · Prostate Hyperplasia
Enrolling by invitation NCT05832268
— Observational Norway
Obstetric Anal Sphincter Injury · Anal Incontinence · Urinary Incontinence
Not yet recruiting NCT06099990
Phase I Interventional —
High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
Recruiting NCT05899361
No phase Interventional United States
Urologic Cancer · Urologic Neoplasms · Bladder Cancer
Not yet recruiting NCT06093568
— Observational United States
Renal Cell Carcinoma
Recruiting NCT03034187
— Observational Netherlands
Prostate Cancer
Not yet recruiting NCT06085378
No phase Interventional China
Acute Ischemic Stroke · Type 2 Diabetes
Not yet recruiting NCT06070272
— Observational United States
Recurrent Prostate Cancer
Recruiting NCT03216525
Phase III Interventional United States
Bladder Cancer
Recruiting NCT05832736
No phase Interventional Italy
Prostate Cancer
Recruiting NCT04549688
No phase Interventional Norway
Prostate Cancer
Recruiting NCT06050148
Phase II / Phase III Interventional Finland
Recurrent Urinary Tract Infection
Recruiting NCT03379909
Phase II Interventional Netherlands
Superficial Bladder Cancer · Bladder Cancer
Not yet recruiting NCT06032728
No phase Interventional —
Renal Cell Carcinoma
Recruiting NCT05620784
Phase III Interventional United States
BPH With Urinary Obstruction · BPH · Hematuria
Recruiting NCT05600127
Phase II Interventional Netherlands
Urothelial Carcinoma
Recruiting NCT06026189
No phase Interventional Netherlands
Hematuria · Urothelial Neoplasm · Urothelial Carcinoma
Recruiting NCT05224401
Phase III Interventional Sweden
Urinary Tract Infections · Bacteremia · Antibiotic Resistant Infection
Not yet recruiting NCT06009549
— Observational United States
Metastatic Prostate Cancer
Not yet recruiting NCT06009510
— Observational United States
Bladder Cancer
Recruiting NCT05689866
— Observational France
Urinary Bladder Sphincter Disorder